Platomics announces new collaborations Read the Press Releases
IVDR 2.0 and Article 5(5): What Could Change for In-House IVDs?

Most of the regulatory debate over the past years has focused on manufacturers under the In Vitro Diagnostic Regulation (IVDR). For laboratories, however, one provision has always been central: Article 5(5), the in-house exemption. With the proposed revision of the…








